Hi, what are you looking for?
Jewish Business News
Search results for " Erez Vigodman"
Business
Teva appointed Dr. Yitzhak Peterburg as Interim, succeeding Erez Vigodman. Dr. Sol J. Barer named Chairman of the Board
Business
– – Please help us out : Will you offer us a hand? Every gift, regardless of size, fuels our future. Your critical contribution...
Business
– Bonuses could boost Erez Vigodman’s compensation to $4.1 million annually, not including options. – – The basic salary of incoming Teva Pharmaceutical Industries Ltd. (NYSE:TEVA;...
Money
– Teva’s board is due to meet within days to approve Erez Vigodman’s appointment as CEO. – – Erez Vigodman, 54, a board member...
Business
It's tictoc, tictoc, for Teva.
Business
Last week Teva CEO, Erez Vigodman said, “If the Mylan Pharmaceuticals shareholders support the acquisition of Perrigo, Teva will abandon its bid for Mylan.”
Business
Teva Chairman Yitzhak Peterburgand and Teva’s CEO Erez Vigodman, are pushing Mylan to take Teva’s $40 billion take-over bid offer seriously.
Business
[FULL LETTER] After Mylan Responded aggressively to Teva's bid, Erez Vigodman says in an open letter to Robert Coury: Shareholders won't benefit from Mud...
Business
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
Court
According to the lawsuit, Teva paid illegal payments of more than $ 300 million to two charities in 2006-2015, to cover deductibles in the...